UAE In Vitro Diagnostics Market to grow at a CAGR of 5.16% to 2029
Increasing healthcare infrastructure and
a supportive regulatory environment are the major drivers for the UAE In Vitro Diagnostics Market.
According to TechSci Research report, “UAE
In Vitro Diagnostics Market Industry Size, Share, Trends, Competition,
Opportunity and Forecast, 2019-2029”,
UAE In Vitro Diagnostics Market has valued at USD 306.57 million in 2023 and is
anticipated to witness an impressive growth in the forecast period with a CAGR
of 5.16% through 2029. This
can be due to collaborations and partnerships among leading companies with a
diverse approach to merge the expertise of individual companies and to
strengthen their position.
Medical tourism contributes to the
demand for In Vitro Diagnostics (IVD) by influencing healthcare-seeking
behavior, especially when individuals travel internationally for medical
treatments. Individuals
seeking medical treatments abroad often undergo comprehensive diagnostic
screenings before their travels. These screenings help assess their health
status, identify potential risks, and ensure they are fit for travel and
medical procedures. Certain
medical treatments and procedures may require specific diagnostic tests before,
during, and after the intervention. Medical tourists may undergo these tests to
facilitate personalized treatment plans and ensure optimal outcomes.
Medical tourism destinations often offer
health check-up packages that include a range of diagnostic tests. These
packages are designed to provide a thorough assessment of the patient's health
and may include tests related to cardiology, gastroenterology, oncology, and
more. Depending on the
destination, medical tourists may undergo diagnostic tests to screen for health
concerns prevalent in the region. This is particularly relevant for infectious
diseases or conditions influenced by geographical factors. After undergoing
medical procedures, patients may need ongoing monitoring through diagnostic
tests to assess treatment effectiveness, identify potential complications, and
ensure a smooth recovery process.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE In Vitro Diagnostics Market”
In
March 2023, Mylab Discovery Solutions has recently entered an exclusive
strategic collaboration with AstraGene LIC to develop automated molecular
diagnostics tailored for the markets of UAE and Kuwait. The partnership entails
joint efforts by Mylab and AstraGene in the creation of molecular diagnostic
solutions, encompassing reagents, kits, and fully automated devices. This
venture represents Mylab's latest venture into international markets, aligning
with its long-term strategy to enhance global accessibility to high-quality
diagnostics. Integral to upgrading laboratory infrastructure in the UAE and
Kuwait, this collaboration will facilitate the installation of advanced
diagnostic systems in laboratories. The collective efforts of the two companies
aim to deliver world-class molecular diagnostic solutions, supporting the
healthcare sectors of the UAE and Kuwait and providing innovative testing
options for patients.
Disease
burden and epidemiological trends present challenges in the In Vitro
Diagnostics (IVD) market in the UAE. Understanding the prevalent diseases,
emerging trends, and healthcare needs is crucial for companies operating in the
diagnostic industry. The epidemiological profile in the UAE may be subject to
changes influenced by factors such as lifestyle, demographics, and healthcare
infrastructure development. Companies need to adapt to evolving disease
patterns. The increasing prevalence of non-communicable diseases, such as
cardiovascular diseases, diabetes, and certain cancers, may drive the demand
for specific diagnostic tests. Companies must align their products with the
prevalent disease burden. The occurrence of infectious diseases, including outbreaks,
can impact diagnostic needs. Rapid and accurate diagnostic tests for infectious
diseases become critical during such periods. With a growing population
and aging demographics, there may be an increased focus on diagnostics related
to chronic disease management. Companies should tailor their offerings to
support long-term care and monitoring.
UAE In Vitro Diagnostics
Market is segmented based on Product, Technology, Application, End User, and by
region.
Based
on the Technology, UAE In Vitro Diagnostics Market is segmented into
Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics,
Microbiology, Others. Clinical chemistry, also known as chemical pathology or
clinical biochemistry, is a branch of laboratory medicine within In Vitro
Diagnostics (IVD) that focuses on the analysis of chemical components in blood,
urine, and other bodily fluids. This field plays a crucial role in providing
information about a patient's metabolic and physiological status, aiding in the
diagnosis, monitoring, and management of various diseases and health
conditions. Clinical chemistry tests are instrumental in assessing organ
function, detecting metabolic abnormalities, and evaluating the presence of
specific biomarkers. Most clinical chemistry tests are performed on blood
samples, typically obtained through venipuncture. Blood provides valuable
information about the composition of various substances circulating in the
body. Some clinical chemistry tests are also conducted on urine samples,
providing insights into renal function, metabolic waste elimination, and other
physiological processes.
Based
on Region, Abu Dhabi region held the largest share in the UAE In
Vitro Diagnostics Market. The region may have established strategic
partnerships between local companies, research institutions, and international
players in the IVD sector, fostering innovation and market leadership. The
regulatory environment in Abu Dhabi is conducive to the growth of the IVD
market, with clear guidelines and efficient approval processes, it can
encourage companies to operate and invest in the region. Abu Dhabi's geographical
location and transportation infrastructure may provide easy access to
international markets, facilitating the import and export of diagnostic
products.
Some
of the major companies operating in the UAE In Vitro Diagnostics
Market include:
- Abbott
Laboratories SA.
- bioMérieux
Middle East FZ LLC
- Roche
Diagnostics Middle East FZCO
- Siemens
Healthineers United Arab Emirates
- QIAGEN
Dubai
- Becton
Dickinson And Company UAE
- Thermo
Fischer Scientific UAE
- Sysmex
Middle East FZ-LLC
- Danaher
Corporation UAE
- Bio-Rad
Laboratories UAE
Download free Sample Report
Customers
can also request 10% free customization on this report
“Certain
areas, particularly in Dubai, are projected to exert significant demand for In
Vitro Diagnostics. The growth in the competitive landscape and the presence of
well-established companies in the market, committed to enhance the overall
wellbeing of people each year, are expected to contribute to a remarkable
growth of the UAE In Vitro Diagnostics Market in the forecast
period," said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based Global management consulting firm.
UAE In Vitro Diagnostics Market by
Product (Instruments, Reagents, Software & Services), By Technology
(Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics,
Microbiology, Others), By Application (Infectious Diseases, Diabetes, Oncology,
Cardiology, Nephrology, Others), By End User (Hospitals & Clinics,
Diagnostic Centers & Laboratories, Others), By Region, By
Competition Forecast & Opportunities, 2019-2029F has evaluated
the future growth potential of UAE In Vitro Diagnostics Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide innovative market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in UAE In Vitro Diagnostics Market.
Contact
TechSci Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com